Why visceral fat is bad: mechanisms of the metabolic syndrome (Q36461889)

14 August 2017

1 reference

title

Why visceral fat is bad: mechanisms of the metabolic syndrome (English)

1 reference

14 August 2017

1 reference

Morvarid Kabir

6

0 references

author name string

Richard N Bergman

1

1 reference

14 August 2017

Stella P Kim

2

1 reference

14 August 2017

Karyn J Catalano

3

1 reference

14 August 2017

Isabel R Hsu

4

1 reference

14 August 2017

Jenny D Chiu

5

1 reference

14 August 2017

Katrin Hucking

7

1 reference

14 August 2017

Marilyn Ader

8

1 reference

14 August 2017

1 February 2006

1 reference

14 August 2017

1 reference

14 August 2017

14 Suppl 1

1 reference

14 August 2017

16S-19S

1 reference

Insulin signaling is required for insulin's direct and indirect action on hepatic glucose production

14 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.277

Maturation of neuronal excitability in hippocampal neurons of mice chronically exposed to cyclic hypoxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.277

Global and societal implications of the diabetes epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.277

Obesity, insulin resistance, and cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.277

Pathways from obesity to hypertension: from the perspective of a vicious triangle

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.277

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.277

Regulation of fasted blood glucose by resistin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.277

ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.277

Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.277

Contribution of abdominal adiposity to age-related differences in insulin sensitivity and plasma lipids in healthy nonobese women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.277

Regional adiposity and morbidity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.277

Analysis of the relationship between body mass index, insulin resistance, and beta-cell function: a cross-sectional study using the minimal model.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.277

Primacy of Hepatic Insulin Resistance in the Development of the Metabolic Syndrome Induced by an Isocaloric Moderate-Fat Diet in the Dog

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.277

Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.277

Free fatty acids impair hepatic insulin extraction in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.277

Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.277

31 March 2020

Identifiers

DOI

10.1038/OBY.2006.277

1 reference

14 August 2017

1 reference